EGM
IGMS

Engineers Gate Manager’s IGM Biosciences IGMS Stock Holding History

Engineers Gate Manager’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,734
Closed -$136K – 1931
2023
Q2 		$136K Buy
+14,734
New +$165K 0.01% 1532
2022
Q3 		– Sell
-11,531
Closed -$208K – 1831
2022
Q2 		$208K Buy
+11,531
New +$206K 0.01% 1616

Other funds holding IGMS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Engineers Gate Manager's IGMS Position: Q3 2023 in Review

Engineers Gate Manager sold out of IGM Biosciences (IGMS) in Q3 2023, closing a stake of 14,734 shares — an estimated $136K sold.

Engineers Gate Manager first reported a position in IGMS in Q2 2022 and held it in 2 quarters. The position peaked at $208K in Q2 2022. 79 funds tracked by Wall St. Rank hold IGMS as of Q3 2023.

  • Engineers Gate Manager reported no remaining IGM Biosciences position as of Q3 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 14,734 IGM Biosciences shares in Q3 2023, an estimated $136K.
  • Engineers Gate Manager first reported a position in IGM Biosciences in Q2 2022 and held it in 2 quarters.
  • Engineers Gate Manager's IGM Biosciences position peaked at $208K in Q2 2022.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2023.

Based on Engineers Gate Manager's 13F filing for Q3 2023, filed 14 Nov 2023.